Switch to:
More From Other Websites
Seattle Genetics Initiates Phase 1b Trial of SGN-CD33A in Combination with Frontline Standard of... Dec 18 2014
Seattle Genetics and Takeda Announce Four-Year Survival Data from ADCETRIS® (Brentuximab Vedotin)... Dec 08 2014
Seattle Genetics and Takeda Report Phase 3 AETHERA Clinical Trial Data from ADCETRIS(R) (Brentuximab... Dec 08 2014
Seattle Genetics Presents Data from Novel Antibody-Drug Conjugate SGN-CD33A at ASH Annual Meeting Dec 08 2014
Seattle Genetics Presents ADCETRIS® (Brentuximab Vedotin) Data in Diffuse Large B-cell Lymphoma at... Dec 08 2014
Seattle Genetics Presents Data from Novel Antibody-Drug Conjugate SGN-CD33A at ASH Annual Meeting Dec 08 2014
Seattle Genetics Presents ADCETRIS® (Brentuximab Vedotin) Data in Diffuse Large B-cell Lymphoma at... Dec 08 2014
Seattle Genetics CEO: Blockbuster cancer drug? Dec 08 2014
Seattle Genetics-Takeda's Adcetris Shows Long-Term Effect Dec 08 2014
Seattle Genetics Highlights Multiple ADCETRIS® (Brentuximab Vedotin) Data Presentations in... Dec 08 2014
Seattle Genetics Highlights Multiple ADCETRIS® (Brentuximab Vedotin) Data Presentations in... Dec 08 2014
Seattle Genetics and Takeda Report Phase 3 AETHERA Clinical Trial Data from ADCETRIS® (Brentuximab... Dec 08 2014
Seattle Genetics and Takeda Announce Four-Year Survival Data from ADCETRIS® (Brentuximab Vedotin)... Dec 07 2014
Seattle Genetics and Takeda Announce Four-Year Survival Data from ADCETRIS® (Brentuximab Vedotin)... Dec 07 2014
Seattle Genetics and Takeda Announce Four-Year Survival Data from ADCETRIS® (Brentuximab Vedotin)... Dec 07 2014
Seattle Genetics Presents Data from SGN-CD19A Antibody-Drug Conjugate at ASH Annual Meeting Dec 06 2014
Seattle Genetics Presents Data from SGN-CD19A Antibody-Drug Conjugate at ASH Annual Meeting Dec 06 2014
Seattle Genetics and Takeda Report Phase 3 AETHERA Clinical Trial Data from ADCETRIS® (Brentuximab... Dec 06 2014
Seattle Genetics and Takeda Report Phase 3 AETHERA Clinical Trial Data from ADCETRIS® (Brentuximab... Dec 06 2014
Seattle Genetics and Takeda Report Phase 3 AETHERA Clinical Trial Data from ADCETRIS® (Brentuximab... Dec 06 2014


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK